CHA Cord Blood Bank

CHA Biotech, which operates the CHA Cord Blood Bank under the brand name i-Cord, is a leading South Korean biotechnology company specializing in stem cell research, regenerative medicine, and cell therapy development. As a cornerstone of the CHA Health Systems, the company provides comprehensive cord blood and tissue banking services, utilizing advanced cryopreservation technologies to store hematopoietic and mesenchymal stem cells for future therapeutic use. Beyond its banking operations, CHA Biotech maintains a robust R&D pipeline featuring natural killer (NK) cell therapies for solid tumors and mesenchymal stem cell (MSC) treatments for conditions such as cerebral palsy, stroke, and degenerative disc disease. The company also operates a global contract development and manufacturing organization (CDMO) through its subsidiary Matica Biotechnology and manages an extensive international network of hospitals and fertility centers.